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hypoxia and the Warburg phenotype in squamous
cell carcinomas of the vulva
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and Heinz Schmidberger1Abstract
Background: Strongly increased uptake of glucose is a hallmark of solid malignant tumors. This phenotype can be
triggered by hypoxia-induced gene expression changes or can occur independently of hypoxia as a consequence
of malignant transformation itself, and is often referred to as the Warburg effect. The glycolytic phenotype has been
associated with malignant progression and resistance to radio- and chemotherapy.
Methods: We have chosen squamous cell carcinomas of the vulva (SCC-V) as a representative solid tumor entity to
study the central players of this pathway, namely glucose transporter (GLUT)-1, carbonic anhydrase (CA) IX, hexokinase
(HK)-2 and pyruvate kinase (PK)-M2, and have investigated their relationships to tumor microvessels (CD34, αSMA) and
proliferation (Ki67). Expression of these proteins was analyzed in 38 SCC-Vs, 5 vulvar dysplasias and 10 non-neoplastic
squamous epithelia of the vulva using multiparametric immunohistochemistry in registered serial sections (MIRSS).
Results: Expression of GLUT-1 in invasive carcinomas was predominantly located in the outer layers of the tumor cell
aggregates close to the vascularized tumor stroma, and only to a lesser extent colocalized with CA IX, which was repeatedly
found at larger diffusion distances away from microvessels. CA IX expression was lower in invasive carcinomas compared to
dysplasias and non-neoplastic tissue and higher in recurrent vs. primary tumors. Ki67-positive proliferating cells were partially
colocalized with GLUT-1. However, HK-2 and PK-2 - proteins centrally involved in the Warburg phenotype - did not show
such a correlation.
Conclusions: Consistent with prior studies, the pattern of GLUT-1 clearly indicated that a large part of its expression is
presumably unrelated to hypoxia. However, there was also no association with HK-2 and PK-M2, suggesting that
the functional background of this expression is also independent of aerobic glycolysis. CA IX may be worth consideration
as a marker of biological hypoxia, as should its pathophysiological consequences in SCC-V.
Keywords: Vulvar carcinoma, Hypoxia, Glucose transporter, Carbonic anhydrase IX, Hexokinase 2, Pyruvate kinase M2,
Warburg effectBackground
The glucose transporter (GLUT)-1 and carbonic anhy-
drase (CA) IX are upregulated by the transcription factor
hypoxia-inducible factor (HIF)-1. Since more than 50% of
solid malignant tumors contain hypoxic tissue areas [1], it
is not surprising that these entities have a high prevalence
of expression of these proteins. In addition, a prevailing* Correspondence: arnmayer@uni-mainz.de
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CA IX since increased uptake of glucose into the (tumor)
cell, and its aerobic glycolysis is associated with an in-
creased production of lactate and protons. Carbonic
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reports which have described a co-expression of GLUT-1
and CA IX in vivo. These include, e.g., the data presented
by Rademakers et al. on squamous cell carcinoma of the
head and neck [5], Airley et al. [6] on cervical cancer as
well as our own recent communication on glioblastomas
[7]. Due to the fact that a large number of clinical studies
have identified correlations between the expression of
GLUT-1 and CA IX and a poorer patient prognosis [8],
many authors believe that the glycolytic phenotype is
also causally involved in the pathogenesis, progression and
therapeutic resistance of malignant disease (see [9] for an
overview). Of importance is the finding of Sattler et al.
[10], who have recently shown that increased concen-
trations of lactate and pyruvate - end products of aerobic
glycolysis - strongly correlate with resistance to fraction-
ated radiotherapy. Moreover, there is also significant evi-
dence supporting glycolysis-mediated resistance to some
forms of chemotherapy (e.g., [11]).
Squamous cell carcinomas of the vulva (SCC-V) are
a relatively rare entity, but become much more preva-
lent with increasing patient age (17/100,000 women
over 75 years, [12]). Patient prognosis is determined
most strongly by the depth of tumor invasion into the
underlying stroma and a proportional increase in the
occurrence of lymph node metastases. Primary therapy
traditionally consisted of radical surgery, but this strat-
egy has largely been abandoned in favor of multimodal
approaches which integrate less extensive surgery with
neoadjuvant or adjuvant radiotherapy (±chemotherapy)
in order to improve both oncologic results and patient
quality of life.
In the present work, we have investigated central ele-
ments of putative hypoxic and glycolytic phenotypes in
SCC-V, since they may be relevant for the efficacy of
neoadjuvant/adjuvant treatment regimes. SCC-V have
been reported to be hypoxic by us [13] and others [14],
but we also considered hypoxia-independent glycoly-
sis, as outlined above. We have employed multipara-
metric immunohistochemistry in registered serial sections
(MIRSS), a novel technique developed in our laboratory
[7], which allows correlation of multiple antigens. Using
this method we have analyzed the spatial expression
patterns of GLUT-1 and CA IX in relation to (i) each
other, (ii) the CD34/αSMA-positive tumor microvas-
culature, (iii) Ki67-positive proliferating cells and (iv)
two key proteins widely believed to be causally involved in
the “Warburg phenotype” of hypoxia-independent, aerobic
glycolysis of malignant cells, hexokinase (HK)-2 [15]
and pyruvate kinase (PK)-M2 [16]. In addition to 38
invasive SCC-Vs, 5 vulvar dysplasias and 10 non-
neoplastic tissue specimens of the vulva containing
squamous epithelium were analyzed using the same
methodology.Methods
Tissue specimens
Histological sections of 38 invasive squamous cell carcin-
omas of the vulva, 5 vulvar intraepithelial neoplasias and 10
non-neoplastic specimens containing squamous epithelium
were obtained from the archive of the Department of
Obstetrics and Gynecology, University Medical Center,
Mainz. The study has been approved by the local medical
ethics committee (Ethikkommission der Landesärztekammer
Rheinland-Pfalz, No. 837.287.05). Clinical data of these
patients are listed in Additional file 1: Table S1.
Immunohistochemistry
Serial sections of 3 μm were prepared from paraffin blocks
using a high-precision microtome and dried overnight at
37°C (Histology core facility, University Medical Center,
Mainz). On the next day, specimens were dewaxed in two
changes of fresh xylene and then rehydrated in a descend-
ing alcohol series. Retrieval of antigenic binding sites was
performed by heating specimens in appropriate buffers
(see Table 1 for details) in a steamer (Braun FS 10, Braun,
Kronberg, Germany) for 40 min. The primary antibodies
and incubation conditions used are listed in Table 1.
Biotin-free, micropolymer-based Vector Immpress reagents
(Vector Laboratories, Burlingame, CA) were used for the
detection and visualization of primary antibody binding.
Reagents were applied overnight at 4°C. Negative control
specimens were incubated in PBS without the primary anti-
body under the same conditions. Diaminobenzidine (DAB)
was used as the peroxidase substrate. Slides were coun-
terstained with Mayer’s hematoxylin, dehydrated in an
ascending alcohol series, and covered with a coverslip using
Roti-Histokitt mounting medium (Carl Roth, Karlsruhe,
Germany). Digital images of the specimens were acquired
using a histology scanner (OpticLab H850, Plustek, Taipei,
Taiwan). For the analysis of the mean distance to the near-
est microvessel of GLUT-1 and CA IX positive cells in
invasive carcinomas, all CD34, GLUT-1 and CA IX slides
of these specimens were additionally scanned with Leica/
Aperio and Hamamatsu slide scanners at 20x/40x mag-
nification. Only immunostaining compatible with the
known biological function and corresponding subcellular
localization of each antigen was considered as being evalu-
able as marker expression (see Table 1).
Image preparation and registration
To enable spatial correlations, digital images of the scanned
immunostains of GLUT-1 and CA IX (OpticLab scans)
were registered to the corresponding Ki67 image. To
achieve this, each source image (e.g., GLUT-1) and the
corresponding target image (Ki67) were opened simul-
taneously in ImageJ on a 30 inch TFT monitor. Using
the “multipoint tool”, approximately 20 corresponding
landmarks were set in each image. The point selection
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saved to disk for later reference. Using the plugin
“bunwarpj” [17] both images were registered using the fol-
lowing parameters: registration mode: “mono”; initial
deformation: “fine”, final deformation: “super fine”, land-
mark weight =1, image weight =0.5, Verbose = yes. All
other parameters were left at their default settings. Using
this method, registration results showed geometric cor-
respondence down to the level of relevant microstruc-
tures. For the analysis of the mean distance to the nearest
microvessel in virtual slides (Leica and Hamamatsu scans),
20x/40x images were first reduced to a size which
retained sufficient resolution for this type of analysis
while being small enough (typically between 50 and
150 Megabyte per LZW-compressed TIFF image) to
enable their processing in ImageJ [18]. This step was
carried out in Image Pro Premier (IPP, Media Cybernetics,
Rockville, MD). Images were then registered in a similar
fashion as described above. However, since the distance
analysis is critically dependent upon the utmost achievable
precision of the registration process, we typically used 100
landmarks for each image (200 for each pair). CD34
specimens were used as the target images for both
GLUT-1 and CA IX. Since (in our hands) the “bunwarpj”
plugin (used for the slightly smaller OpticLab scans) was
not able to register some of the larger images in this
series, we used the ImageJ plugin “Landmark corre-
spondences” instead [19], which consistently showed
very good results with these large images. Representa-
tive examples of the registration results are shown in
Additional file 2: Figure S1.
Quantification of marker expression (OpticLab scans)
The extent of the expression of GLUT-1, CA IX, and
Ki67 was quantified as the positive fraction of the totalevaluable tumor area (of the entire histological section).
Marker positive pixels were highlighted by color thresh-
olding in Adobe Photoshop CS5 using the “wand tool”,
while simultaneously examining the corresponding glass
slides under the microscope to avoid the inclusion of re-
gions that did not correspond to cancer cells. This was
especially important in the case of GLUT-1, which is not
only found in cancer cells but also exhibits a physio-
logical expression in the cell membrane of red blood
cells. Pixels thus labeled as positive for GLUT-1, CA IX
and Ki67 were stored in the green, red and blue chan-
nels, respectively, of a new RGB (“merge”) image, which
had the same pixel dimensions as the corresponding
original digitized tumor specimens (Figure 1). To define
the pixel size of the total tumor surface area (as opposed
to the total surface area of the entire digitized specimen,
which included various amounts of surrounding normal
tissue), the section stained for CA IX was used as a repre-
sentative reference. Here, the tumor area was marked
manually in Adobe Photoshop CS5 using the lasso tool
and subsequently converted to a black and white mask
image which was saved to a file. The pixel dimensions of
the tumor area were then quantified in ImageJ. For mea-
surements of the percentage of positive tumor area for
GLUT-1, CA IX and Ki 67, the number of positive pixels
belonging to each of these antigens was determined using
ImageJ’s "Color inspector 3D" plugin and related to the
total tumor area. The extent of colocalization between
GLUT-1 and CA IX was calculated as the percentage of
colocalized pixels relative to the sum of the pixels of both
antigens. To quantify the relationship of the expression of
the aforementioned markers with proliferation, we calcu-
lated how many Ki67-positive pixels were simultaneously
positive for GLUT-1 alone, both for GLUT-1 and CA IX
or CA IX alone.
Figure 1 Detail from a merged image of three registered entire
tumor sections stained for GLUT-1, CA IX and Ki67. Thresholded
positive pixels are shown in green, red and blue, respectively. Overlap
between GLUT-1 and CA IX is shown in yellow, pixels positive for
GLUT-1 and Ki67 are shown in cyan. White bar =1 mm.
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microvessel of GLUT-1 and CA IX in invasive carcinomas
(Aperio/Hamamatsu scans)
Registered CD34, GLUT-1 and CA IX sections were con-
verted to an image stack using ImageJ. This stack was
imported into IPP and the tumor area was outlined as a
region of interest (ROI). Further steps were carried out in
this ROI only. CD34 positive microvessels, GLUT-1 and
CA IX positive pixels were identified by thresholding in
the HSL (hue, saturation, luminance) color space and con-
verted to black and white masks. The CD34 mask image
was converted to a 32 bit euclidean distance trans-
formation, in which each grey value corresponds to the
distance (in pixels) to the nearest microvessel. Grey values
were consecutively converted to a calibrated distance
(in μm). GLUT-1 and CA IX mask images and the dis-
tance transformation image were once again imported
into ImageJ. GLUT-1 and CA IX positive pixels were
turned into pixel “selections” which then were redirected
to the distance transformation image to obtain the mean
calibrated distance of the expression of each marker rela-
tive to the nearest microvessel.Statistical analysis
All statistical tests were performed using the SPSS software
package (Version 21, IBM, Armonk, NY). The significance
level was set at α=5% for all comparisons. Linear correla-
tions between two variables were described by Spearman's
rank correlation coefficient (ρ). Two-sided Mann–Whitney
U tests were used for comparison of categorized variables.
A two-sided Wilcoxon test was used for the analysis of the
distances of GLUT-1 and CA IX (paired samples) relative
to CD34 positive blood vessels.Results
Visual assessment of the expression patterns
In a first step, the expression patterns of all antigens were
evaluated visually. In addition to viewing the slides with a
light microscope at 10x or 20x magnification to assess de-
tails, low magnification views of sets of 4 complete digital
tumor specimens, each stained for a different antigen and
arranged in the same spatial orientation as the others were
viewed side by side on a 30 inch monitor. GLUT-1 and
CA IX were expressed in all specimens, but the extent of
this expression varied considerably. In all non-neoplastic
tissues and in most (i.e., 4 of 5) of the dysplasias, GLUT-1
was expressed most strongly in the cell layers immediately
adjacent to the stroma and its intensity decreased and
ultimately disappeared with increasing distance from
the stromal compartment. Conversely, in both non-
neoplastic tissues and dysplasias, the expression of CA
IX persistently showed an opposite pattern with an expres-
sion intensity which increased with the cells’ distance from
the stroma. Overlap of both proteins occurred in a zone
between the aforementioned hotspots, but the extent of
this zone was typically quite limited. Expression of GLUT-
1 in non-neoplastic tissues and dysplasias colocalized with
Ki67 positive (proliferating) cells, which, as expected,
were located in the basal layer(s) of the squamous epi-
thelia. Interestingly, a similar spatial distribution of the
three antigens was also observed as the predominant
pattern in the invasive carcinomas (Figure 2). Since a
distant, “hypoxia-inducible” expression of GLUT-1 may be
expected for this HIF-1 target gene, we subsequently refer
to this GLUT-1 pattern as the “inverse” type, whereas the
CA IX pattern was considered “typical” for a hypoxia-
regulated protein (see discussion). The relationship between
CD34, GLUT-1, CA IX and Ki67 was further characterized
in quantitative analyses (see below).
HK-2 and PK-M2 showed a weaker and more diffuse ex-
pression pattern compared to the aforementioned antigens
(Additional file 3: Figure S2). Since there was only negli-
gible variation in the expression intensity of these antigens,
quantitative colocalization analyses, e.g., with GLUT-1 and
CA IX, would not have yielded additional information and
have thus been omitted. It was evident from visual inspec-
tion alone that correlations between either HK-2 or PK-
M2 with GLUT-1 or CA IX were definitely lacking.
As anticipated, the endothelial marker CD34 and smooth
muscle actin (αSMA) exhibited a strong spatial association
in and around intratumoral microvessels, with αSMA
positive cells surrounding CD34-positive endothelial cells,
in keeping with the known expression of αSMA in peri-
cytes and vascular smooth muscle cells. Hence, α-SMA
served as a biological plausibility control for the detection
of CD34 positive microvessels. In addition, an independent
subset of αSMA-positive cells showing no relationship
to microvessels was observed in varying proportions.
Figure 2 Representative colocalization patterns of GLUT-1, CA IX, CD34 and Ki67 in an invasive squamous cell carcinoma of the vulva.
GLUT-1 (upper left panel) is expressed preferentially in the outer layers of the tumor cell aggregates, while CA IX (upper right panel) is expressed
at a distance from the stroma, which contains CD34-positive tumor microvessels (middle left panel). The lower left panel shows a merged image
of thresholded positive pixels of GLUT-1 (green), CA IX (red) and CD34 (blue) and illustrates minimal overlap (yellow) between GLUT-1 and CA IX.
It also underscores the aforementioned spatial relationships of GLUT-1 and CA IX with CD34-positive microvessels (blue). Ki67-positive proliferating
cells (middle right panel) are found in the same compartment as GLUT-1 positive cells. Conversely, the expression of Ki67 and CA IX is virtually
mutually exclusive. The lower right panel shows a merged image of thresholded positive pixels of GLUT-1 (green), CA IX (red) and Ki67 (blue).
Any overlap between Ki67 and GLUT-1 and Ki67 and CA IX is visible in cyan and pink colors, respectively. All panels: cropped frames from 10x
magnification digital images.
Figure 3 Box and whisker plots illustrating the percentages of
pixels positive for CA IX relative to the total tumor area in
invasive carcinomas, dysplasias and non-neoplastic tissue.
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ance with the literature, these cells most probably repre-
sent (activated) myofibroblasts.
Quantitative evaluation of the registered serial sections
Antigen-positive area fractions
In a first quantitative analysis, we tested whether GLUT-1-,
CA IX-, and KI 67-positive fractions of the entire tumor
areas were distributed differently in invasive tumors,
dysplasias and non-neoplastic squamous epithelium.
Surprisingly, the non-neoplastic tissue specimens showed
a significantly higher CA IX expression compared to the
dysplasias (p =0.026) and in particular, to the invasive
carcinomas (p =0.00005, Figure 3, Additional file 1:
Tables S2–S4). Dysplasias also showed a higher prolif-
eration compared to invasive tumors (p =0.026). In in-
vasive carcinomas, the expression of GLUT-1 was much
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ratio of GLUT-1 positive pixels to CA IX positive pixels,
which had a median value of 6.5), whereas this inequality
was significantly less pronounced in dysplasias (p =0.018)
and non-neoplastic tissues (p =0.000004), matching the
lower overall expression of CA IX in invasive carcinomas
(see also Additional file 1: Table S2).Comparison of the expression patterns of GLUT-1 and CA IX
The visual impression of low colocalization of GLUT-1
and CA IX was confirmed in the quantitative analysis.
For this purpose, the percentage of colocalized pixels
relative to the sum of GLUT-1 and CA IX positive pixels
was determined. In the invasive tumors, the coloca-
lized fraction had a median value of only 10.7%. On
the one hand, this value is very low in absolute terms
and on the other hand it is significantly lower than
in the dysplasias (p =0.023) and non-neoplastic tissues
(p =0.0002, Figure 4).Quantitative analysis of the mean distance of GLUT-1 and
CA IX to the nearest microvessel
A comprehensive analysis of the distances of GLUT-1
and CA IX positive pixels relative to the nearest microves-
sels using a distance transformation image of the CD34
microvessel “map” revealed a mean distance of 85 μm (SD
25 μm) for GLUT-1 and 124 μm (SD 32 μm) for CA IX.
This difference was highly significant (p <0.0001). When
looking at individual specimens, not even a single instance
was found in which the mean distance was larger for
GLUT-1 than for CA IX. These findings underscore our
interpretation of an “inverse” expression pattern of GLUT-
1 and a “typical”, hypoxia-related pattern of CA IX.Figure 4 Box and whisker plots illustrating the percentages of
pixels positive for both GLUT-1 and CA IX relative to all GLUT-
1- and CA IX-positive pixels in invasive carcinomas, dysplasias
and non-neoplastic tissue.Expression of GLUT-1 and CA IX in relation to proliferation
(Ki67)
In all three types of tissue, Ki67-positive pixels were also
positive for GLUT-1 (but not for CA IX) in a high percent-
age, positive for both GLUT-1 and CA IX to a lesser degree,
and positive for CA IX (but not GLUT-1) only on rare occa-
sions (p <0.0000001 for both comparisons to the first group,
see Figure 5).
Differences between primary and recurrent tumors
The recurrent tumors (n =16) had a significantly higher
expression (p =0.042) of CA IX as compared to the primary
tumors (n =22); see Figure 6. In addition, the percent-
age of Ki67-positive pixels that were also positive for both
GLUT-1 and CA IX were higher in the recurrent tumors
(p =0.048).
Discussion
From the present study we have obtained novel and par-
tially unexpected insights into the pathophysiological ram-
ifications of the expression of the hypoxia-associated
markers GLUT-1 and CA IX in squamous cell carcin-
omas of the vulva. Using polarographic needle electrodes,
studies by Stone et al. [14] and Vaupel et al. [13] have de-
scribed profound hypoxia in squamous cell carcinomas of
the vulva. However, we [20,21] and others [22,23] have also
reported earlier that the expression intensity of GLUT-1
and CA IX is not directly proportional to microregional
hypoxia, using the same method. Consistent with these lat-
ter data, the present study describes a largely inverse, i.e.,
hypoxia-independent expression pattern of GLUT-1 and a
diminished expression of CA IX in invasive tumors com-
pared to dysplasias and non-malignant vulvar squamousFigure 5 Grouped Box and whisker plots illustrating the
percentages of pixels positive for Ki67 and GLUT-1, CA IX or
both proteins grouped by invasive carcinomas (light grey) and
dysplasias/non-neoplastic tissue (dark grey).
Figure 6 Box and whisker plots illustrating the percentages of
pixels positive for CA IX relative to the total tumor area in
primary vs. recurrent invasive carcinomas.
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been made in a prior study [24], but these authors did not
carry out quantitative analyses. Indeed, we observed a
median 6.5-fold higher expression of GLUT-1 compared
to CA IX in the invasive tumors, whereas the preponder-
ance of GLUT-1 in dysplasias and non-neoplastic tissues
was significantly less pronounced. Constitutive expression
of GLUT-1 has been reported, e.g., in red blood cells, nor-
mal capillaries of the brain and in the parathyroid gland,
while expression of CA IX is typically found in the normal
epithelia of stomach and gallbladder [25]. Expression of
these proteins has also been described in normal vulvar
tissue and vulvar dysplasias in earlier studies, but was found
to be weaker compared to the invasive lesions [26,27]. Dis-
parate findings between these and our communications
may in part relate to the fact that we have performed quan-
titative analyses on complete surgical specimens while the
previous investigators carried out semiquantitative analyses
in biopsy specimens [26] or tissue microarrays [27]. Never-
theless, the finding of a reduced CA IX expression in inva-
sive lesions in our study is surprising. Although one of the
aforementioned studies which have directly measured the
oxygenation of vulvar carcinomas [13] included meas-
urement of normal tissue, these data were obtained in the
mons pubis, not in normal healthy vulvar tissue. There-
fore, it cannot be excluded that normal vulvar epithelium
indeed contains hypoxic areas which have not yet been
recognized. Owing to the highly diffuse infiltrative nature
of vulvar carcinoma, which is an important factor regard-
ing the unfavorable clinical tendency of the disease to
recur, better oxygenation of invasive tumors compared to
the corresponding normal tissues seems conceivable due
to the fact that the tumor infiltrates into a highly vascular
connective tissue. The finding of a higher CA IX expressionin our study in recurrent tumors is consistent with this
idea, since vascularity and the resulting oxygen transport
capacity of connective tissue are often compromised after
previous surgery or radiotherapy.
Our data further indicate a preferential colocalization
of Ki67 with GLUT-1, but not with CA IX in invasive
carcinomas, similar to the findings in dysplastic lesions
and non-neoplastic tissues. These data are consistent with
the largely inverse expression of GLUT-1 in the outer layers
of the cancer cell aggregates and the expression of CA
IX in tumor areas at a greater distance from neighboring
microvessels. Hence, CA IX positive subvolumes are pre-
sumably poorly perfused and represent hypoxic tissue areas.
The inhibitory effect of chronic hypoxia on cell prolif-
eration has long been recognized [28]. At first glance,
these data might suggest the conjecture that a hypoxia-
independent glycolytic phenotype associated with cell prolif-
eration, compatible with Warburg's original hypothesis, is
present in SCC-V. However, we could not establish evidence
supporting such an interpretation. Both HK-2 and PK-M2
are considered to be of central functional importance
for aerobic glycolysis [15,16], yet their expression patterns
lacked any clear association with either GLUT-1 or CA IX
in our study. The possibility, however, that different results
might be obtained with other antibody clones, cannot be
completely ruled out. Our results should, therefore, be
regarded as preliminary at this point in time. Nevertheless,
under conditions of a highly active glycolytic metabol-
ism with resultant accumulation of pyruvate and lactate
(Warburg phenotype), induction of HIF-1α would be ex-
pected to occur in the GLUT-1 positive tumor areas ac-
cording to the findings of Lu et al. [29], which should then,
in turn, transactivate CA IX in the same tumor microre-
gions, since CA IX is known to be one of the most robust
and strongly induced target genes of HIF-1 [30,31]. Hence,
doubts regarding the equivalence of GLUT-1 staining with
an active “Warburg-type” metabolism in our study may in
fact be valid.
The expression pattern of GLUT-1, as described in the
present study, may neither be related to hypoxia nor to
“aerobic glycolysis”, i.e., the Warburg effect. The increased
glucose uptake capacity of GLUT-1 positive cells near the
tumor stroma may have a different purpose, which is inde-
pendent of energy metabolism. It is conceivable, e.g., that a
high glucose uptake is necessary to provide ribose-5-
phosphate for DNA synthesis, which is supplied by reac-
tions of the pentose phosphate cycle. The latter pathway is
also important for the regeneration of reduced glutathione,
which may be crucial for the protection of the integrity of
the DNA of proliferating cells against oxygen radicals.
Finally, glyceraldehyde-3-phosphate, a glycolytic intermedi-
ate, is a building block for phospholipids and triacylglycerols,
which are essential for the assembly of the cell membranes
of newly generated cells.
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It can be stated that the expression of GLUT-1 in vulvar
cancers is significantly different from the pattern found
in some other tumor entities, and may be derived from
physiological characteristics of the proliferative compart-
ment of the vulvar squamous epithelium and comman-
deered by the neoplastic cells derived from it. The pressing
question as to whether the loss of hypoxia-independent ex-
pression of GLUT-1 in subregions of vulvar carcinomas is
equivalent to dedifferentiation and may be associated with
a poorer patient prognosis should be answered in a future
study with a significantly higher number of patients. Con-
versely, the expression pattern of CA IX is compatible with
a marker function for local hypoxia, although probably not
on an absolute scale, as has been demonstrated in cancers
of the uterine cervix [20]. Reduction of CA IX in vulvar car-
cinomas may indicate that the invasion of these vulvar can-
cer cells may be in part driven by hypoxia, a possibility that
warrants investigation in further experimental, translational
and clinical studies.
Additional files
Additional file 1: Tables S1–S4. These tables contain clinical/
histopathological data (Additional file 1: Table S1) and details regarding
the antigen-positive tumor areas in invasive carcinomas, dysplasias and
non-neoplastic tissue of the vulva (Additional file 1: Tables S1–S4).
Additional file 2: Figure S1. Details from the registration of GLUT-1
and CA IX to CD34 using the Aperio and Hamamatsu scans. Each row
represents a different tumor.
Additional file 3: Figure S2. Staining patterns of GLUT-1 (upper left
panel), CA IX (lower left panel), Hexokinase-2 (HK-2, upper right panel)
and pyruvate kinase type M2 (PK-M2, lower right panel). GLUT-1 and CA
IX both show a clearly demarcated and strong signal which is unequivocally
restricted to a subtype of the cells present in the tissue slice. Conversely,
HK-2 and PK-M2 staining is weak and more diffusely distributed throughout
the tumor section. Images show the same subregion of the tumor but have
not been registered using the described methodology.
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